Andrew Grimm, MD, PhD
Vice President -- Global Clinical Development for Metabolic Diseases
Current Institution: Ultragenyx Pharaceutical Inc.
Undergraduate School : Massachusetts Institute of Technology, 2000
Graduate Program: Washington University School of Medicine, 2008
Program of Study: Molecular Genetics and Genomics
Thesis Lab: Shin-ichiro Imai, MD, PhD
Thesis Title: The function and regulation of Sirt1